REQUEST A DEMO
Total
USD $0.00
Search more companies

Organon Pharma d.o.o. (Croatia)

Main Activities: Advertising Agencies
Full name: Organon Pharma d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Organon Pharma d.o.o. is an enterprise based in Croatia. Its main office is in Zagreb. The company operates in the Advertising Agencies industry. Organon Pharma d.o.o. was incorporated on January 14, 2026. There are currently 10 (2024) people employed by Organon Pharma d.o.o.. From the latest financial highlights, Organon Pharma d.o.o. reported a net sales revenue drop of 21.92% in 2024. During that time, Organon Pharma d.o.o.’s total assets decreased by 4.24%. The net profit margin of Organon Pharma d.o.o. decreased by 14.11% in 2024.

Headquarters
Slavonska Avenija 1C Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Organon Pharma d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Organon Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Organon Pharma d.o.o. report to view the information.
Incorporation Date:
January 14, 2026
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Organon Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-21.92%
Total operating revenue
-21.92%
Operating profit (EBIT)
-61.15%
EBITDA
-60.67%
Net Profit (Loss) for the Period
-72.92%
Total Assets
-4.24%
Total Equity
156.42%
Operating Profit Margin (ROS)
-12.9%
Net Profit Margin
-14.11%
Return on Equity (ROE)
-516.63%
Debt/Equity
-786.86%
Quick Ratio
1.94%
Cash Ratio
1.88%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?